Cargando…

A quality-of-life system to evaluate children with leukemia in China

The scale for assessing the quality of life (QOL) of children with leukemia of different ages is vacant in China. Items for developing a QOL scale were selected through a literature review, interviews with 58 parents and children with leukemia by Delphi method, which involved pediatric oncologists,...

Descripción completa

Detalles Bibliográficos
Autores principales: Wang, Zijuan, Mo, Lin, Jiang, Xiaoping, Liu, Yang, Shi, Lin
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Wolters Kluwer Health 2018
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6133475/
https://www.ncbi.nlm.nih.gov/pubmed/30200097
http://dx.doi.org/10.1097/MD.0000000000012119
Descripción
Sumario:The scale for assessing the quality of life (QOL) of children with leukemia of different ages is vacant in China. Items for developing a QOL scale were selected through a literature review, interviews with 58 parents and children with leukemia by Delphi method, which involved pediatric oncologists, psychologists, and pediatricians. The initial items were formulated through 2 rounds of the Delphi method and statistical analyses. The formulated scale was pre-tested for reliability and validity. A method was adopted to weight the importance of items within the evaluation index system. The final scale includes 5 dimensions. There are 10 secondary items for age 2 to 4 years, 12 secondary items for all other age groups, and 29, 46, 52, and 50 tertiary items for the age groups 2 to 4 years, 5 to 7 years, 8 to 12 years, and 13 to 18 years, respectively. The authority coefficient for experts was 0.75, with Kendall's W coefficient P < .01, for both rounds. The entire Cronbach alpha was >0.9, and the content validity >0.75. The weights of the first-grade items are: 0.201, 0.203, 0.198, 0.201, and 0.198. This quality-of-life scale for children with leukemia in China has demonstrated reliability and validity, while a further validity assessment is required.